Rizatriptan

Table   Graphic     exposition period:

Congenital malformations
Adverse outcome PastilleOR 95%CII2k No. casesNo. exposedpublication biasROB???
All congenital malformations (majors, minors, majors and minors, or unspecified)insufficient precision0.83 [0.48, 1.43]0%2 studies56,797467not evaluable NApptx
1 non statistically significant endpoints reported in only one study

Growth parameters and prematurity
Adverse outcome PastilleOR 95%CII2k No. casesNo. exposedpublication biasROB???
Preterm (< 37 weeks)no evidence of harm0.48 [0.26, 0.88]-1 study47334not evaluable NApptx
2 non statistically significant endpoints reported in only one study

Maternal consequences
Adverse outcome PastilleOR 95%CII2k No. casesNo. exposedpublication biasROB???
1 non statistically significant endpoints reported in only one study

Neonatal disorders
Adverse outcome PastilleOR 95%CII2k No. casesNo. exposedpublication biasROB???
1 non statistically significant endpoints reported in only one study